Stem cells for bronchopulmonary dysplasia: A promising yet challenging journey lies ahead
We congratulate the authors for their commendable effort in conducting a phase I clinical trial on stem cell in prevention of bronchopulmonary dysplasia (BPD).1 With increased survival of extremely low birth weight infants, BPD has emerged as a major morbidity in this population.2 Regenerative medicine in the form of stem cell therapy seems to be a promising solution for healing the affected lungs in this population.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tanushree Sahoo, Krishna Mohan Gulla Tags: Letters to the Editor Source Type: research
More News: Bronchopulmonary Dysplasia | Clinical Trials | Pediatrics | Stem Cell Therapy | Stem Cells